{"id":"https://openalex.org/W2977481237","doi":"https://doi.org/10.2217/fmb-2019-0135","title":"Eravacycline: A New Treatment Option for Complicated Intra-Abdominal Infections in the Age of Multidrug Resistance","display_name":"Eravacycline: A New Treatment Option for Complicated Intra-Abdominal Infections in the Age of Multidrug Resistance","publication_year":2019,"publication_date":"2019-10-01","ids":{"openalex":"https://openalex.org/W2977481237","doi":"https://doi.org/10.2217/fmb-2019-0135","mag":"2977481237","pmid":"https://pubmed.ncbi.nlm.nih.gov/31570004"},"language":"en","primary_location":{"id":"doi:10.2217/fmb-2019-0135","doi":"https://doi.org/10.2217/fmb-2019-0135","is_oa":false,"landing_page_url":"https://doi.org/10.2217/fmb-2019-0135","pdf_url":null,"source":{"id":"https://openalex.org/S129524704","display_name":"Future Microbiology","issn_l":"1746-0913","issn":["1746-0913","1746-0921"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310321119","host_organization_name":"Future Medicine","host_organization_lineage":["https://openalex.org/P4310321119"],"host_organization_lineage_names":["Future Medicine"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Future Microbiology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5003906647","display_name":"Joseph S. Solomkin","orcid":"https://orcid.org/0000-0001-6382-4902","observed_orcids":["https://orcid.org/0000-0001-6382-4902"]},"institutions":[{"id":"https://openalex.org/I63135867","display_name":"University of Cincinnati","ror":"https://ror.org/01e3m7079","country_code":"US","type":"education","lineage":["https://openalex.org/I63135867"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joseph S Solomkin","raw_affiliation_strings":["Department of Surgery, University of Cincinnati College of Medicine, 6005 Given Road Cincinnati, OH45243, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Surgery, University of Cincinnati College of Medicine, 6005 Given Road Cincinnati, OH45243, USA","institution_ids":["https://openalex.org/I63135867"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015448893","display_name":"Angie Sway","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Angie Sway","raw_affiliation_strings":["Medical Writing, World Surgical Infection Society, Cincinnati, OH45243, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Writing, World Surgical Infection Society, Cincinnati, OH45243, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063713898","display_name":"Kenneth R Lawrence","orcid":"https://orcid.org/0000-0003-2694-5216","observed_orcids":["https://orcid.org/0000-0003-2694-5216"]},"institutions":[{"id":"https://openalex.org/I4210151614","display_name":"Tetraphase Pharmaceuticals (United States)","ror":"https://ror.org/048830f73","country_code":"US","type":"company","lineage":["https://openalex.org/I4210151614"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kenneth Lawrence","raw_affiliation_strings":["Medical Affairs, Tetraphase Pharmaceuticals, Watertown, MA02472, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Affairs, Tetraphase Pharmaceuticals, Watertown, MA02472, USA","institution_ids":["https://openalex.org/I4210151614"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084066242","display_name":"Melanie Olesky","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210151614","display_name":"Tetraphase Pharmaceuticals (United States)","ror":"https://ror.org/048830f73","country_code":"US","type":"company","lineage":["https://openalex.org/I4210151614"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Melanie Olesky","raw_affiliation_strings":["Medical Affairs, Tetraphase Pharmaceuticals, Watertown, MA02472, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Affairs, Tetraphase Pharmaceuticals, Watertown, MA02472, USA","institution_ids":["https://openalex.org/I4210151614"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084528915","display_name":"Sergey Izmailyan","orcid":"https://orcid.org/0000-0001-9589-7399","observed_orcids":["https://orcid.org/0000-0001-9589-7399"]},"institutions":[{"id":"https://openalex.org/I4210151614","display_name":"Tetraphase Pharmaceuticals (United States)","ror":"https://ror.org/048830f73","country_code":"US","type":"company","lineage":["https://openalex.org/I4210151614"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sergey Izmailyan","raw_affiliation_strings":["Medical Affairs, Tetraphase Pharmaceuticals, Watertown, MA02472, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Affairs, Tetraphase Pharmaceuticals, Watertown, MA02472, USA","institution_ids":["https://openalex.org/I4210151614"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5088076252","display_name":"Larry W. Tsai","orcid":"https://orcid.org/0000-0002-4787-2100","observed_orcids":["https://orcid.org/0000-0002-4787-2100"]},"institutions":[{"id":"https://openalex.org/I4210151614","display_name":"Tetraphase Pharmaceuticals (United States)","ror":"https://ror.org/048830f73","country_code":"US","type":"company","lineage":["https://openalex.org/I4210151614"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Larry Tsai","raw_affiliation_strings":["Medical Affairs, Tetraphase Pharmaceuticals, Watertown, MA02472, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Affairs, Tetraphase Pharmaceuticals, Watertown, MA02472, USA","institution_ids":["https://openalex.org/I4210151614"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.1892,"has_fulltext":false,"cited_by_count":21,"citation_normalized_percentile":{"value":0.74968006,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":92,"max":98},"biblio":{"volume":"14","issue":"15","first_page":"1293","last_page":"1308"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10147","display_name":"Antibiotic Resistance in Bacteria","score":0.9560999870300293,"subfield":{"id":"https://openalex.org/subfields/2726","display_name":"Microbiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10147","display_name":"Antibiotic Resistance in Bacteria","score":0.9560999870300293,"subfield":{"id":"https://openalex.org/subfields/2726","display_name":"Microbiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11036","display_name":"Antibiotics Pharmacokinetics and Efficacy","score":0.024900000542402267,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10897","display_name":"Antibiotic Use and Resistance","score":0.008700000122189522,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/eravacycline","display_name":"eravacycline","score":1.0},{"id":"https://openalex.org/keywords/complicated-intra-abdominal-infections","display_name":"complicated intra-abdominal infections","score":0.9150000214576721},{"id":"https://openalex.org/keywords/multidrug-resistance","display_name":"multidrug resistance","score":0.9470000267028809},{"id":"https://openalex.org/keywords/gram-negative-bacteria","display_name":"Gram-negative bacteria","score":0.6959999799728394},{"id":"https://openalex.org/keywords/extended-spectrum-beta-lactamase","display_name":"extended-spectrum beta-lactamase","score":0.8899999856948853},{"id":"https://openalex.org/keywords/carbapenem-resistance","display_name":"carbapenem resistance","score":0.9860000014305115},{"id":"https://openalex.org/keywords/enterobacteriaceae","display_name":"Enterobacteriaceae","score":0.9929999709129333},{"id":"https://openalex.org/keywords/ertapenem","display_name":"ertapenem","score":0.9869999885559082},{"id":"https://openalex.org/keywords/meropenem","display_name":"meropenem","score":1.0},{"id":"https://openalex.org/keywords/clinical-cure-rate","display_name":"clinical cure rate","score":0.628000020980835},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.8259999752044678},{"id":"https://openalex.org/keywords/tetracycline","display_name":"tetracycline","score":0.8360000252723694}],"concepts":[{"id":"https://openalex.org/C2778368673","wikidata":"https://www.wikidata.org/wiki/Q553220","display_name":"Ertapenem","level":5,"score":0.9526182413101196},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8333845734596252},{"id":"https://openalex.org/C2779375183","wikidata":"https://www.wikidata.org/wiki/Q421670","display_name":"Meropenem","level":4,"score":0.8074209094047546},{"id":"https://openalex.org/C3020442560","wikidata":"https://www.wikidata.org/wiki/Q4971815","display_name":"Broad spectrum","level":2,"score":0.5177323222160339},{"id":"https://openalex.org/C2780580376","wikidata":"https://www.wikidata.org/wiki/Q186889","display_name":"Nausea","level":2,"score":0.46628427505493164},{"id":"https://openalex.org/C2776685102","wikidata":"https://www.wikidata.org/wiki/Q410897","display_name":"Carbapenem","level":3,"score":0.42726510763168335},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.3809339106082916},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.3561483323574066},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.29785653948783875},{"id":"https://openalex.org/C94665300","wikidata":"https://www.wikidata.org/wiki/Q63391344","display_name":"Antibiotic resistance","level":3,"score":0.269676148891449},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.2225298285484314},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.09174835681915283},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.0},{"id":"https://openalex.org/C21951064","wikidata":"https://www.wikidata.org/wiki/Q899212","display_name":"Combinatorial chemistry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000077727","descriptor_name":"Ertapenem","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000077731","descriptor_name":"Meropenem","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000900","descriptor_name":"Anti-Bacterial Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001618","descriptor_name":"beta-Lactamases","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003627","descriptor_name":"Data Interpretation, Statistical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004755","descriptor_name":"Enterobacteriaceae","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D004755","descriptor_name":"Enterobacteriaceae","qualifier_ui":"Q000201","qualifier_name":"enzymology","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008826","descriptor_name":"Microbial Sensitivity Tests","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011446","descriptor_name":"Prospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013754","descriptor_name":"Tetracyclines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D015780","descriptor_name":"Carbapenems","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D024901","descriptor_name":"Drug Resistance, Multiple, Bacterial","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D059413","descriptor_name":"Intraabdominal Infections","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D059413","descriptor_name":"Intraabdominal Infections","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D059413","descriptor_name":"Intraabdominal Infections","qualifier_ui":"Q000382","qualifier_name":"microbiology","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.2217/fmb-2019-0135","doi":"https://doi.org/10.2217/fmb-2019-0135","is_oa":false,"landing_page_url":"https://doi.org/10.2217/fmb-2019-0135","pdf_url":null,"source":{"id":"https://openalex.org/S129524704","display_name":"Future Microbiology","issn_l":"1746-0913","issn":["1746-0913","1746-0921"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310321119","host_organization_name":"Future Medicine","host_organization_lineage":["https://openalex.org/P4310321119"],"host_organization_lineage_names":["Future Medicine"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Future Microbiology","raw_type":"journal-article"},{"id":"pmid:31570004","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/31570004","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Future microbiology","raw_type":"Clinical Trial, Phase III"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":75,"referenced_works":["https://openalex.org/W1532733209","https://openalex.org/W1618166169","https://openalex.org/W1967549517","https://openalex.org/W1969500929","https://openalex.org/W1969648832","https://openalex.org/W1976915176","https://openalex.org/W1980538526","https://openalex.org/W2034464820","https://openalex.org/W2041797411","https://openalex.org/W2061669270","https://openalex.org/W2066747009","https://openalex.org/W2070452159","https://openalex.org/W2075303816","https://openalex.org/W2078250306","https://openalex.org/W2087242016","https://openalex.org/W2088452703","https://openalex.org/W2088945335","https://openalex.org/W2104348548","https://openalex.org/W2106373938","https://openalex.org/W2106661305","https://openalex.org/W2115744065","https://openalex.org/W2125808637","https://openalex.org/W2131640216","https://openalex.org/W2135543196","https://openalex.org/W2137290352","https://openalex.org/W2137408524","https://openalex.org/W2149186506","https://openalex.org/W2149315953","https://openalex.org/W2150478590","https://openalex.org/W2154007902","https://openalex.org/W2154994569","https://openalex.org/W2156918227","https://openalex.org/W2163177484","https://openalex.org/W2244655105","https://openalex.org/W2290753892","https://openalex.org/W2294833633","https://openalex.org/W2318653171","https://openalex.org/W2333657865","https://openalex.org/W2339307736","https://openalex.org/W2402307237","https://openalex.org/W2474294795","https://openalex.org/W2527930446","https://openalex.org/W2546641535","https://openalex.org/W2550643720","https://openalex.org/W2583549666","https://openalex.org/W2588446477","https://openalex.org/W2592810481","https://openalex.org/W2603039590","https://openalex.org/W2610760615","https://openalex.org/W2610936380","https://openalex.org/W2616409827","https://openalex.org/W2625287887","https://openalex.org/W2706794697","https://openalex.org/W2729161724","https://openalex.org/W2735724836","https://openalex.org/W2739039423","https://openalex.org/W2740366338","https://openalex.org/W2751939257","https://openalex.org/W2774055322","https://openalex.org/W2777879918","https://openalex.org/W2786886659","https://openalex.org/W2790135539","https://openalex.org/W2795817444","https://openalex.org/W2813628191","https://openalex.org/W2883732289","https://openalex.org/W2888520542","https://openalex.org/W2889629084","https://openalex.org/W2889954524","https://openalex.org/W2892368225","https://openalex.org/W2895593384","https://openalex.org/W2904874168","https://openalex.org/W2911389741","https://openalex.org/W2913156301","https://openalex.org/W2914630764","https://openalex.org/W2937856613"],"related_works":["https://openalex.org/W3017953956","https://openalex.org/W2962248781","https://openalex.org/W2042363266","https://openalex.org/W7100883974","https://openalex.org/W2915523134","https://openalex.org/W2550643720","https://openalex.org/W2945926743","https://openalex.org/W4238022579","https://openalex.org/W3213646299","https://openalex.org/W2904230285"],"abstract_inverted_index":{"Aim:":[0],"Recently":[1],"approved":[2],"for":[3,41,45,49,53,64,73,106,115],"use":[4,107],"in":[5,55,75,108,113],"complicated":[6,109],"intra-abdominal":[7,110],"infection,":[8],"eravacycline":[9,42,50,65],"is":[10,25,85,101],"a":[11,26],"novel":[12],"fluorocycline":[13],"with":[14,88],"broad":[15],"spectrum":[16],"of":[17,29,91,118],"activity":[18],"against":[19],"resistant":[20],"Gram-negative":[21],"pathogens.":[22],"This":[23],"manuscript":[24],"pooled":[27],"analysis":[28],"two":[30],"Phase":[31],"III":[32],"trials.":[33],"Clinical":[34,36],"efficacy:":[35],"cure":[37],"rates":[38,90],"were":[39],"86.8%":[40],"versus":[43,51,66,71],"87.6%":[44],"ertapenem,":[46,68],"and":[47,62,69,94,112,121],"90.8%":[48],"91.2%":[52],"meropenem":[54,74],"the":[56,76,116],"Intent":[57,78],"to":[58,79],"Treat":[59,80],"(micro-ITT)":[60],"populations,":[61],"87.0%":[63],"88.8%":[67],"92.4":[70],"91.6%":[72],"Modified":[77],"(MITT)":[81],"populations.":[82],"Safety:":[83],"Eravacycline":[84,100],"well":[86],"tolerated,":[87],"lower":[89],"nausea,":[92],"vomiting":[93],"diarrhea":[95],"than":[96],"other":[97],"tetracyclines.":[98],"Conclusion:":[99],"an":[102],"effective":[103],"new":[104],"option":[105],"infections,":[111],"particular,":[114],"treatment":[117],"extended-spectrum":[119],"\u03b2-lactamase-":[120],"carbapenem-resistant":[122],"Enterobacteriaceae-expressing":[123],"organisms.":[124]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":6},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2019-10-10T00:00:00"}